Skip to content

International multi-center randomized control trial to investigate efficacy of VR ping-pong rehabilitation therapy for Parkinson disease patients

International multi-center randomized control trial to investigate efficacy of VR ping-pong rehabilitation therapy for Parkinson disease patients - International multi-center randomized control trial of VR ping-pong rehabilitation therapy for Parkinson disease patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057562
Enrollment
50
Registered
2025-04-14
Start date
2025-04-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson disease

Interventions

We provide participants with VR ping pong rehabilitation and also educational newsletters. We provide participents with only educational newsletters.

Sponsors

International University of Health and Welfare
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with Parkinson disease who visit each study site between April 1, 2025, and December 31, 2025. Patients who can provide written informed consent to participate in the study of their own free will. Patients aged between 30 and 80 years at the time of consent. Outpatient status: Limited to outpatients.

Exclusion criteria

Exclusion criteria: Patients with cognitive impairment Patients classified as stage IV or higher according to the Hoehn & Yahr scale for Parkinson disease Patients receiving device-assisted therapy for Parkinson disease Patients with orthopedic conditions such as arthritis or spinal disorders Patients with a history of stroke or peripheral nerve and muscle diseases Patients with significant vision or hearing impairments that prevent the use of a VR headset Patients deemed by the researcher to be at high risk of falling during VR based table tennis exercises Patients who have previously experienced motion sickness symptoms when using VR devices

Design outcomes

Primary

MeasureTime frame
MDS-UPDRS part III score

Secondary

MeasureTime frame
Evaluation of non-motor symptoms: MDS-UPDRS Part I score Evaluation of ADL: MDS-UPDRS Part II score Evaluation of motor complications: MDS-UPDRS Part IV score Evaluation of QOL: Parkinson's Disease Questionnaire (PDQ-8) TUG (Timed Up and Go Test) Presence or absence of VR sickness

Countries

Japan,Asia(except Japan)

Contacts

Public ContactShinsuke Fujioka

Takagi Hospital Department of Neurology

s.fujioka@ihwg.jp(0944)87-0001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026